Target intelligence / Profile preview

Gastric mucosal epithelial cell

Molecular classification
Other
01

Overview

Gastric mucosal epithelial cells form the specialized lining of the stomach, acting as a primary defense against the harsh acidic environment of the gastric lumen [1]. These cells include various subtypes such as surface mucous cells, which secrete a protective layer of mucus and bicarbonate, and parietal cells, which are responsible for hydrochloric acid secretion via the H+/K+-ATPase pump [1, 3]. Their biological function is essential for nutrient digestion and the prevention of autodigestion of the stomach wall [3]. Pathologically, these cells are central to the development of gastritis, peptic ulcers, and gastric adenocarcinoma, often as a result of Helicobacter pylori infection or chemical irritation [2]. While the cell population itself is not a single molecular target, it houses several key therapeutic targets, including the proton pump and histamine H2 receptors, which are modulated by drugs like omeprazole and famotidine to manage acid-related disorders [4]. Chronic damage to these cells can lead to intestinal metaplasia, a precursor to gastric cancer [2]. [1] StatPearls, Physiology, Stomach; [2] NIH, Gastric Cancer; [3] PubMed, Gastric Mucosal Barrier; [4] PubChem, Omeprazole.

Other names
Gastric epitheliumStomach lining cellsSurface mucous cellsFoveolar cellsGastric mucosa
02

Mechanism of action

Pharmacological agents target specific molecular components within these cells, such as inhibiting the H+/K+-ATPase (proton pump) or antagonizing H2 receptors to reduce gastric acid secretion [1, 4].

03

Biological functions

Mucus secretionAcid secretionEnzyme productionBarrier functionCellular regenerationOther
04

Disease associations

CancerInflammationInfection
05

Safety considerations

Risk of gastric atrophyHypergastrinemiaIncreased susceptibility to Clostridioides difficile infectionMalabsorption of micronutrients like Vitamin B12
06

Interacting drugs

Omeprazole

6 more in the full profile.

07

Biomarkers

Pepsinogen I/II ratioGastrin-17Carcinoembryonic antigen (CEA)MUC5AC expression

Beyond the preview

Go deeper on Gastric mucosal epithelial cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric mucosal epithelial cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call